Defense Personnel Support Center, 2800 S 20Th Street, Phila PA 19101-8419

65 -- TREATMENT OF VAGINAL CANDIDIASIS SOL SPO200-95-R-1012 DUE 113095 POC Contact: POC: Andrea J. Ries, pharmd/Drug inform, specialist amedd pharmacoeconomic Center, Attn: Afzg-dl, Bldg 4197, Ft. SAM Houston, TX 78234-5000 phone: 210-221-4314/FAX 210-221-4314, DSN 471-4606 See NOTE: This is not a Solicitation, this is a Market survey which was advertised before in the Commerce businessdaily. This is being resynopsized dueto an ommissiionof the closing date Fo the presentation. See remarks: The pharmacoeconomic Center (PEC) is reviewing infomation to develop analytic methodologies, to evaluate the dtreatment of vollvovaginal candidiasis in the Military Health service system. Manufacturers of products used for the treatement of vulvovaginal candidiasis are invited to present pharmacoeconomic information to the PEC. This information will assist in developing an evaluation Model for product selection for the Tri-service formulary. Types of information being reviewed include head to head effectiveness studie of completing therapies, pharmacoeconomic and/or quality of life studies of vulvovaginal candidiasis, pharmacoepidemiological information or studies of vulvovaginal candidiasis up to one hour is the preferred length of a presentation; not more than two hours will be allotted for a presentation. The last date for the last date for presentations is 30 Nov 96. Contact: Andrea J. Ries, pharm D pharmacoeconomiccenter, Attn: Afzg-dl, Bldg 4197, 2107 17th St., Ft. SAM Houston, TX 7823-5036. The Contracting Officer DPSC-mgab-pea. All responsibel sources may submit a offer which DPSC shall consider. All responsible sources may submit offer which DPSC shall consider(0325)

Loren Data Corp. http://www.ld.com (SYN# 0403 19951122\65-0002.SOL)